ID: ALA3098851

Max Phase: Preclinical

Molecular Formula: C32H26N2O4S

Molecular Weight: 534.64

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(CN2C(=O)/C(=C/c3cccc(OCCc4ccccc4)c3)S/C2=N\c2ccccc2)cc1

Standard InChI:  InChI=1S/C32H26N2O4S/c35-30-29(21-25-10-7-13-28(20-25)38-19-18-23-8-3-1-4-9-23)39-32(33-27-11-5-2-6-12-27)34(30)22-24-14-16-26(17-15-24)31(36)37/h1-17,20-21H,18-19,22H2,(H,36,37)/b29-21-,33-32-

Standard InChI Key:  XUWCDBFDGBEVJM-FKKWPMSPSA-N

Associated Targets(Human)

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T-cell protein-tyrosine phosphatase 1317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Low molecular weight phosphotyrosine protein phosphatase 1161 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Protein-tyrosine phosphatase 1B 163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

C2C12 756 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 534.64Molecular Weight (Monoisotopic): 534.1613AlogP: 6.81#Rotatable Bonds: 9
Polar Surface Area: 79.20Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.12CX Basic pKa: 3.12CX LogP: 7.05CX LogD: 4.26
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.24Np Likeness Score: -1.13

References

1. Ottanà R, Maccari R, Mortier J, Caselli A, Amuso S, Camici G, Rotondo A, Wolber G, Paoli P..  (2014)  Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.,  71  [PMID:24287560] [10.1016/j.ejmech.2013.11.001]

Source